---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-013080"
form_type: "8-K"
ticker: "RNXT"
cik: "0001574094"
company_name: "RenovoRx, Inc."
filed_at: "2026-03-27T23:59:59+00:00"
generated_at: "2026-05-15T08:37:48.543308+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# RenovoRx appoints Ramtin Agah, MD as Executive Chairman; $450K salary + bonus

## Summary
- Ramtin Agah, MD appointed Executive Chairman effective Feb 27, 2026; continues as Chief Medical Officer.
- $450,000 annual base salary, discretionary bonus up to 40% of base (first bonus payable in 2027 for 2026).
- Eligible for annual grants of stock options and other equity awards under Company's 2021 Omnibus Equity Incentive Plan.
- Employment at-will; prior consulting agreement replaced; existing Change in Control and Severance Agreement remains in effect.
- CEO Shaun Bagai remains principal executive officer; Dr. Agah reports directly to Board.

## SEC filing metadata
- accession: 0001493152-26-013080
- form_type: 8-K
- ticker: RNXT
- cik: 0001574094
- company_name: RenovoRx, Inc.
- filed_at: 2026-03-27T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1574094/000149315226013080/0001493152-26-013080-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1574094/000149315226013080/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-013080
- JSON: https://secwatch.observer/filing/0001493152-26-013080.json
- Plain text: https://secwatch.observer/filing/0001493152-26-013080.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.